Guggenheim Reiterates Buy Rating on Adicet Bio Inc. (ACET)

November 7, 2024 6:14 AM EST Send to a Friend
Guggenheim analyst Yatin Suneja reiterated a Buy rating and $7.00 price target on Adicet Bio Inc. (NASDAQ: ACET).The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login